Northwestern Mutual Wealth Management’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.45K Buy
54
+21
+64% +$629 ﹤0.01% 3677
2025
Q4
$1.02K Buy
33
+7
+27% +$218 ﹤0.01% 3621
2025
Q3
$797 Sell
26
-12
-32% -$292 ﹤0.01% 3586
2025
Q2
$785 Buy
+38
New +$780 ﹤0.01% 3413
2025
Q1
Sell
-379
Closed -$7.91K 3778
2024
Q4
$7.91K Buy
379
+213
+128% +$4.68K ﹤0.01% 2820
2024
Q3
$4.05K Sell
166
-257
-61% -$6.87K ﹤0.01% 2955
2024
Q2
$10.6K Buy
423
+215
+103% +$6.1K ﹤0.01% 2623
2024
Q1
$6.22K Sell
208
-18
-8% -$529 ﹤0.01% 2779
2023
Q4
$7.2K Buy
226
+145
+179% +$4.55K ﹤0.01% 2748
2023
Q3
$2.86K Sell
81
-99
-55% -$3.77K ﹤0.01% 2891
2023
Q2
$6.84K Buy
180
+71
+65% +$2.83K ﹤0.01% 2686
2023
Q1
$4.12K Sell
109
-1
-0.9% -$38 ﹤0.01% 2804
2022
Q4
$4.66K Buy
+110
New +$4.53K ﹤0.01% 2743
2022
Q2
Sell
-10
Closed 3285
2022
Q1
$0 Sell
10
-5,642
-100% -$194K ﹤0.01% 3222
2021
Q4
$224K Buy
5,652
+5,537
+4,815% +$231K ﹤0.01% 1388
2021
Q3
$5K Buy
+115
New +$5.16K ﹤0.01% 2666
2021
Q2
Sell
-59
Closed -$2K 3070
2021
Q1
$2K Buy
59
+51
+638% +$1.92K ﹤0.01% 2603
2020
Q4
$0 Sell
8
-157
-95% -$5.87K ﹤0.01% 2765
2020
Q3
$6K Buy
+165
New +$5.97K ﹤0.01% 2130
2020
Q2
Sell
-47
Closed -$1K 2502
2020
Q1
$1K Sell
47
-21
-31% -$468 ﹤0.01% 2397
2019
Q4
$2K Sell
68
-18
-21% -$393 ﹤0.01% 2221
2019
Q3
$2K Buy
+86
New +$1.69K ﹤0.01% 2270

Other funds holding GMAB

Northwestern Mutual Wealth Management's GMAB Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its Genmab (GMAB) stake by 64% in Q1 2026, buying an estimated $629 and bringing the position to 54 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #3677.

Northwestern Mutual Wealth Management first reported a position in GMAB in Q3 2019 and has held it in 22 quarters since. The position peaked at $224K in Q4 2021. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Northwestern Mutual Wealth Management held 54 shares of Genmab worth $1.45K as of Q1 2026.
  • Northwestern Mutual Wealth Management bought 21 Genmab shares in Q1 2026, an estimated $629.
  • Genmab made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3677 holding.
  • Northwestern Mutual Wealth Management first reported a position in Genmab in Q3 2019 and has held it in 22 quarters since.
  • Northwestern Mutual Wealth Management's Genmab position peaked at $224K in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.